Skip to main content
. 2021 Jul 15;9:655152. doi: 10.3389/fcell.2021.655152

FIGURE 3.

FIGURE 3

Target IL1/LIF/JAK/STAT 3 pathway, which could activate iCAFs in pancreas. It may become potentially effective targeted therapies for PDAC. IL-1β, interleukin-1β; IL-1R, interleukin-1 receptor; LIF, leukemia inhibitory factor; JAK, Janus kinase; STAT 3, signal transducer and activator of transcription 3; iCAFs, inflammatory cancer-associated fibroblasts.